Literature DB >> 26461962

Placental volume, vasculature and calcification in pregnancies complicated by pre-eclampsia and intra-uterine growth restriction.

Mary C Moran1, Cecelia Mulcahy2, Gergely Zombori3, John Ryan2, Paul Downey2, Fionnuala M McAuliffe2.   

Abstract

OBJECTIVE: Pre-eclampsia (PET) and intrauterine growth restriction (IUGR), often associated with impaired placental function, are among the most common conditions contributing to increased perinatal mortality and morbidity. This study investigates if three dimensional power Doppler (3DPD) of the placenta and computerised analysis of placental calcification is different between PET/IUGR and normal pregnancies. STUDY
DESIGN: This was a prospective cohort study involving 50 women with pre-eclampsia and/or IUGR, or with IUGR only from 24 to 40 weeks' gestation. 3DPD ultrasound was used to calculate placental volume, vascularisation index (VI), flow index (FI) and vascularisation-flow index (VFI). Following each scan the percentage of placental calcification was also calculated, by computer analysis. Results were compared with normal (control) values, and findings correlated with maternal and fetal Doppler parameters and placental histology.
RESULTS: Volume, VI, and VFI are not influenced by gestational age in PET/IUGR pregnancies. FI was found to increase with gestational age (p=0.009) and was lower than normal in the total study group from 24 to 30 weeks (p=0.006). In the pregnancies affected by PET, whether or not IUGR was present, all three indices were lower than normal values between 24 and 30 weeks (VI: p=0.038, FI: p=0.004, VFI: p=0.015). Vascularisation and flow indices were less than the normal 50th centile in the majority of cases of utero-placental insufficiency (p=0.047), and vascularisation and vascularisation flow indices were lower in cases of accelerated placental maturation (p=0.016 and 0.041 respectively). Placental volume greater than the 50th centile between 24 and 30 weeks was associated with the presence of infarction on histology (p=0.021). Flow index (p=0.002) and vascularisation flow index (p=0.036) were lower in the presence of bilateral uterine artery notches. Calcification, similar to the control group, was related to an increasing UAPI (p=0.041) and MCA PI <5th centile (p=0.010).
CONCLUSIONS: The study findings suggest that there may be a role for 3DPD placental assessment of volume, vascularisation and blood flow and computer analysis of placental calcification in the identification and management of PET/IUGR pregnancy.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Calcification of calcification; Intrauterine growth restriction; Placental vasculature; Placental volume; Pre-eclampsia

Mesh:

Year:  2015        PMID: 26461962     DOI: 10.1016/j.ejogrb.2015.07.023

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.831


  14 in total

1.  The eutheria-specific miR-290 cluster modulates placental growth and maternal-fetal transport.

Authors:  Alireza Paikari; Cassandra D Belair; Daniel Saw; Robert Blelloch
Journal:  Development       Date:  2017-09-21       Impact factor: 6.868

Review 2.  Effects of maternal obesity on placental function and fetal development.

Authors:  Kristy R Howell; Theresa L Powell
Journal:  Reproduction       Date:  2016-11-18       Impact factor: 3.906

3.  In vivo assessment of placental and brain volumes in growth-restricted fetuses with and without fetal Doppler changes using quantitative 3D MRI.

Authors:  N Andescavage; A duPlessis; M Metzler; D Bulas; G Vezina; M Jacobs; S N Iqbal; A Baschat; C Limperopoulos
Journal:  J Perinatol       Date:  2017-08-24       Impact factor: 2.521

4.  Comparison of Placental Three-Dimensional Power Doppler Vascular Indices and Placental Volume in Pregnancies with Small for Gestational Age Neonates.

Authors:  Sue-Jar Chen; Chie-Pein Chen; Fang-Ju Sun; Chen-Yu Chen
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

5.  A Case of Vaginal Stillbirth in the Presence of Placenta Previa at 33 Weeks of Gestation.

Authors:  Yukiko Chinen; Tadatsugu Kinjo; Hayase Nitta; Yui Kinjo; Hitoshi Masamoto; Yoichi Aoki
Journal:  Case Rep Obstet Gynecol       Date:  2016-08-07

6.  Changes in Intra-Amniotic, Fetal Intrathoracic, and Intraperitoneal Pressures with Uterine Contraction: A Report of Three Cases.

Authors:  Daisuke Katsura; Yuichiro Takahashi; Shigenori Iwagaki; Rika Chiaki; Kazuhiko Asai; Masako Koike; Shunsuke Yasumi; Madoka Furuhashi
Journal:  Case Rep Obstet Gynecol       Date:  2018-09-12

7.  Mechanobiological regulation of placental trophoblast fusion and function through extracellular matrix rigidity.

Authors:  Zhenwei Ma; Lucas Sagrillo-Fagundes; Stephanie Mok; Cathy Vaillancourt; Christopher Moraes
Journal:  Sci Rep       Date:  2020-04-03       Impact factor: 4.379

8.  Increased Angiogenesis and Lymphangiogenesis in the Placental Villi of Women with Chronic Venous Disease during Pregnancy.

Authors:  Miguel A Ortega; Miguel A Saez; Oscar Fraile-Martínez; Ángel Asúnsolo; Leonel Pekarek; Coral Bravo; Santiago Coca; Felipe Sainz; Melchor Álvarez- Mon; Julia Buján; Natalio García-Honduvilla
Journal:  Int J Mol Sci       Date:  2020-04-03       Impact factor: 5.923

9.  Upregulation of VEGF and PEDF in Placentas of Women with Lower Extremity Venous Insufficiency during Pregnancy and Its Implication in Villous Calcification.

Authors:  Miguel A Ortega; Miguel Ángel Saez; Ángel Asúnsolo; Beatriz Romero; Coral Bravo; Santiago Coca; Felipe Sainz; Melchor Álvarez-Mon; Julia Buján; Natalio García-Honduvilla
Journal:  Biomed Res Int       Date:  2019-12-09       Impact factor: 3.411

10.  Impact of maternal obesity on placental transcriptome and morphology associated with fetal growth restriction in mice.

Authors:  Daniela de Barros Mucci; Laura C Kusinski; Phoebe Wilsmore; Elena Loche; Lucas C Pantaleão; Thomas J Ashmore; Heather L Blackmore; Denise S Fernandez-Twinn; Maria das Graças T do Carmo; Susan E Ozanne
Journal:  Int J Obes (Lond)       Date:  2020-03-13       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.